Edwards Lifesciences at deutsche bank 2026 healthcare summit: broader growth
At a glance
- $EW today−0.04%last $107.11
- Vs industry peers+0.86 pts6-peer median −0.90% · ahead
- Since Sep 16+21.4%from the first trade after the story
- 52-week range0.8% below high$74.66 – $107.98
- Last reported profit$307.5Mquarter to Sep 30, 2026 · 10-Q
- Coverage2 this week2 in 30 days · too few stories to call a pace
Nothing reported about Edwards Lifesciences across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Options price an average move of ±6.6% by Dec 18 — the at-the-money straddle, the typical size of the move; the bands are one standard deviation.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: De-escalation tends to ease energy and shipping costs first, which is where markets feel geopolitics most directly.
- How the stock is trading: $EW -0.04% in the latest session.
- Timing: It was published while New York was trading, so the day's move may already include the first reaction.
Where the stock stands
Edwards Lifesciences Corporatio ($EW) slipped 0.04% to $107.11 in the latest session. Over the past month it is up 22.8%. It now sits 0.8% under the 52-week high of $107.98 and 43% above the year's low of $74.66, close to the top of its range. The high sits 45% above the low, a moderate range for a year.
What the filings say
In its latest report (10-Q, filed Nov 4, 2026), $EW earned $307.5M over the quarter to Sep 30, 2026 on revenue of $1.72B (-1.5% QoQ). Operations brought in $1.27B of cash over the nine months to Sep 30, 2026; after capital spending, free cash flow was $1.07B. It carried $598.8M of debt against $3.11B of cash on Sep 30, 2026 — net cash of $2.51B. Its most recent filings before this story: 8-K on Aug 28, 2026, 10-Q on Aug 4, 2026, 8-K on Jul 23, 2026. Figures are as filed with the SEC; the $EW page has the full statements.
How much coverage it is getting
This story is more than a month old. Since then Wook has filed 2 newer stories on Edwards Lifesciences Corporatio in the last 30 days, 2 of them this week. By their wording, 0 read bullish, 2 neutral and 0 bearish.
The bigger picture
Geopolitical stories reach markets through specific pipes — energy and shipping costs, sanctions, tariffs and defense budgets — so the useful question is which pipe a story touches, not how dramatic the headline sounds. Wook's supply-chain scanner shows no unusual stress in Health Care today.
What to watch next
For the company's side of it, read its latest SEC filings on the $EW page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Where several outlets agree is usually the news; where they differ is the angle. To run the numbers yourself, ask Wook AI above about $EW: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on September 16, 2026. $EW has moved +21.37% ($88.25 to $107.11). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
